Insights

Loading spinner
Gathering insights about Taysha Gene Therapies

Taysha Gene Therapies Tech Stack

Taysha Gene Therapies uses 8 technology products and services including Google Font API, GSAP, React, and more. Explore Taysha Gene Therapies's tech stack below.

  • Google Font API
    Font Scripts
  • GSAP
    Javascript Frameworks
  • React
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • PWA
    Miscellaneous
  • Webpack
    Miscellaneous
  • HTTP/3
    Miscellaneous
  • Priority Hints
    Performance

Taysha Gene Therapies's Email Address Formats

Taysha Gene Therapies uses at least 1 format(s):
Taysha Gene Therapies Email FormatsExamplePercentage
flast@tayshagtx.comJDoe@tayshagtx.com
93%
flast@tayshagtx.comJDoe@tayshagtx.com
5%
lfirst@tayshagtx.comDJohn@tayshagtx.com
1%
first@tayshagtx.comJohn@tayshagtx.com
1%

Frequently Asked Questions

Where is Taysha Gene Therapies's headquarters located?

Minus sign iconPlus sign icon
Taysha Gene Therapies's main headquarters is located at Dallas, TX US. The company has employees across 3 continents, including North AmericaEuropeAfrica.

What is Taysha Gene Therapies's stock symbol?

Minus sign iconPlus sign icon
Taysha Gene Therapies is a publicly traded company; the company's stock symbol is TSHA.

What is Taysha Gene Therapies's official website and social media links?

Minus sign iconPlus sign icon
Taysha Gene Therapies's official website is tayshagtx.com and has social profiles on LinkedIn.

How much revenue does Taysha Gene Therapies generate?

Minus sign iconPlus sign icon
As of April 2024, Taysha Gene Therapies's annual revenue reached $15M.

What is Taysha Gene Therapies's SIC code NAICS code?

Minus sign iconPlus sign icon
Taysha Gene Therapies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Taysha Gene Therapies have currently?

Minus sign iconPlus sign icon
As of April 2024, Taysha Gene Therapies has approximately 83 employees across 3 continents, including North AmericaEuropeAfrica. Key team members include Chief Technical Officer: F. P.Chief Financial Officer: K. A.Chief Medical Officer: M. S.. Explore Taysha Gene Therapies's employee directory with LeadIQ.

What industry does Taysha Gene Therapies belong to?

Minus sign iconPlus sign icon
Taysha Gene Therapies operates in the Biotechnology Research industry.

What technology does Taysha Gene Therapies use?

Minus sign iconPlus sign icon
Taysha Gene Therapies's tech stack includes Google Font APIGSAPReactSlickPWAWebpackHTTP/3Priority Hints.

What is Taysha Gene Therapies's email format?

Minus sign iconPlus sign icon
Taysha Gene Therapies's email format typically follows the pattern of . Find more Taysha Gene Therapies email formats with LeadIQ.

How much funding has Taysha Gene Therapies raised to date?

Minus sign iconPlus sign icon
As of April 2024, Taysha Gene Therapies has raised $40M in funding. The last funding round occurred on Dec 19, 2023.

When was Taysha Gene Therapies founded?

Minus sign iconPlus sign icon
Taysha Gene Therapies was founded in 2020.
Taysha Gene Therapies

Taysha Gene Therapies

Biotechnology ResearchTexas, United States51-200 Employees

Taysha Gene Therapies is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. With a singular focus on developing transformative medicines, Taysha aims to address severe unmet medical needs and dramatically improve the lives of patients and their caregivers. The Company’s management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing process and a clinically and commercially proven AAV9 capsid in an effort to rapidly translate treatments from bench to bedside.

Section iconCompany Overview

Headquarters
Dallas, TX US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TSHA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconFunding & Financials

  • $40M

    Taysha Gene Therapies has raised a total of $40M of funding over 7 rounds. Their latest funding round was raised on Dec 19, 2023.

  • $10M$50M

    Taysha Gene Therapies's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $40M

    Taysha Gene Therapies has raised a total of $40M of funding over 7 rounds. Their latest funding round was raised on Dec 19, 2023.

  • $10M$50M

    Taysha Gene Therapies's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.